Similar articles

• Can preoperative PSA doubling time and PSA velocity predict outcomes following radical prostatectomy?

  Grubb RL 3rd, Andriole GL. Grubb RL 3rd, et al. Nat Clin Pract Urol. 2006 Jun;3(6):306-7. doi: 10.1038/ncpuro0476. Nat Clin Pract Urol. 2006. PMID: 16763640 No abstract available.
• Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.

  Höltl W, Lunglmayr G. Höltl W, et al. Wien Klin Wochenschr. 2005 Jul;117(13-14):440-1. doi: 10.1007/s00508-005-0398-8. Wien Klin Wochenschr. 2005. PMID: 16091868 No abstract available.
• Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

  Rosser CJ, Parker A. Rosser CJ, et al. J Urol. 2005 Sep;174(3):1154-5; author reply 1155-6. doi: 10.1097/01.ju.0000169211.49050.8f. J Urol. 2005. PMID: 16094093 No abstract available.
• [Detection of prostate cancer: yes or no?].

  Van Cangh PJ. Van Cangh PJ. Bull Mem Acad R Med Belg. 2006;161(3-4):159-69. Bull Mem Acad R Med Belg. 2006. PMID: 17172224 Review. French. No abstract available.
• [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].

  Bratt O, Björk T. Bratt O, et al. Lakartidningen. 2007 Nov 14-20;104(46):3460-4. Lakartidningen. 2007. PMID: 18072615 Review. Swedish. No abstract available.